High prevalence of obstructive airways disease in hospitalized patients with community-acquired pneumonia: Comparison of four etiologies

Clinical Pulmonary Medicine

Volumn 12, Issue 5, 2005, Pages 291-296

  Boersma, Wim G ^a   Sportel, Johannes H ^b   Löwenberg, Alfred ^b   Koëter, Gerard H ^b  

^a Location Alkmaar   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Asthma; Community acquired pneumonia; COPD; Pulmonary function test

Indexed keywords

HISTAMINE;

ADULT; AGED; ALLERGY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HOSPITAL PATIENT; HUMAN; LEGIONELLA PNEUMOPHILA; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOPLASMA PNEUMONIAE; OBSTRUCTIVE AIRWAY DISEASE; PREVALENCE; QUESTIONNAIRE; SKIN TEST; SMOKING; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 26444446029     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000181649.09072.29     Document Type: Article

References (33)

1. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis. 1989;2:586-599.
2. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine. 1990;69:307-316.
3. White RJ, Blainey AD, Harrison KJ, et al. Causes of pneumonia presenting to district general hospital. Thorax. 1981;36:566-570.
4. Sullivan RJ, Dowdle WR, Marine WM, et al. Adult pneumonia in a general hospital. Arch Intern Med. 1972;129:935-942.
5. Jansen HM, Sachs AP, van Alphen L. Predisposing conditions to bacterial infections in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;151:2073-2080.
6. Fekety FR, Caldwell J, Gump D, et al. Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. Am Rev Respir Dis. 1971;104:499-507.
7. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. Eur Respir J. 1995;8:1694-1698.
8. Wallace RJ, Musher DM, Martin RR. Hemophilus influenzae pneumonia in adults. Am J Med. 1978;64:87-93.
9. Brand PL, Rijcken B, Schouten JP, et al. Perception of airway obstruction in a random population sample. Relationship to airway hyperresponsiveness in the absence of respiratory symptoms. Am Rev Respir Dis. 1992;146:396-401.
10. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J. 1993;6(suppl 16):53-83.
11. Boersma WG, Löwenberg A, Holloway Y, et al. Pneumococcal capsular antigen detection and pneumococcal serology in patients with community-acquired pneumonia. Thorax. 1991;46:902-906.
12. Quanjer PH, Tammeling GJ, Cotes E, et al. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(suppl 16):5-40.
13. Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. Thorax. 1992;47:429-436.
14. Brand PL, Kerstjens HA, Jansen HM, et al. Interpretation of skin tests to house dust mite and relationship to other allergy parameters in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993;91:560-570.
15. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163:1256-1276.
16. US Department of Health and Human Services. Global initiative for asthma management and prevention. NHLBI/WHO workshop report, US Department of Health and Human Services. National Institutes of Health, Bethesda, MD, 1995; Pub #95-3659.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77-S121.
18. Macfarlane JT, Finch RG, Ward MJ, et al. Hospital study of adult community-acquired pneumonia. Lancet. 1982;2:255-258.
19. Almirall J, Morato I, Riera F, et al. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur Respir J. 1993;6:14-18.
20. Karalus NC. Community-acquired pneumonia: aetiology and prognostic index evaluation. Thorax. 1991;46:413-418.
21. Bates JH, Campbell GD, Barren AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest. 1992;101:1005-1012.
22. Laitinen LA, Miettinen AK, Kuosma E, et al. Lung function impairment following mycoplasmal and other acute pneumonias. Eur Respir J. 1992;5:670-674.
23. Benusiglio LN, Stalder H, Junod AF. Time course of lung function changes in atypical pneumonia. Thorax. 1980;35:586-592.
24. Macfarlane JT, Morris MJ. Abnormalities in lung function following clinical recovery from Mycoplasma pneumoniae pneumonia. Eur J Respir Dis. 1982;63:337-341.
25. Melbye H, Kongerud J, Vorland L. Reversible airflow limitation in adults with respiratory infection. Eur Respir J. 1994;7:1239-1245.
26. Colp CR, Park KK, Williams P. Pulmonary functions studies in pneumonia. Am Rev Respir Dis. 1962;3:808-815.
27. Amar RL, Greenberg SB. Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent. Semin Respir Infect. 1989;4:19-31.
28. Busse WW. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J Allergy Clin Immunol. 1990;85:671-683.
29. Paoletti P, Viegi G, Carrozzi L. Bronchial hyperresponsiveness, genetic predisposition and environmental factors: the importance of epidemiological research. Eur Respir J. 1992;5:910-912.
30. Peat JK, Woolcock AJ, Cullen K. Decline of lung function and development of chronic airflow limitation: a longitudinal study of nonsmokers and smokers in Busselton, Western Australia. Thorax. 1990;45:32-37.
31. Woodhead MA, Macfarlane JT, Mccracken JS, et al. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987;1:671-674.
32. Woodhead MA, Macfarlane JT. Legionnaires' disease: a review of 79 community acquired cases in Nottingham. Thorax. 1986;41:635-640.
33. Stout JE, Yu VL. Legionellosis. N Engl J Med. 1997;337:682-687.